Literature DB >> 28237629

Effectiveness of pre-treatment with chlorhexidine in restoration retention: A 36-month follow-up randomized clinical trial.

Morgana Favetti1, Thaiane Schroeder1, Anelise Fernandes Montagner2, Marcos Britto Correa1, Tatiana Pereira-Cenci1, Maximiliano Sergio Cenci3.   

Abstract

OBJECTIVES: This study evaluated the effect of the pre-treatment with 2% chlorhexidine digluconate (CHX) as coadjutant in restoration retention of noncarious cervical lesions (NCCL), after 36 months of follow-up.
METHODS: A randomized controlled split-mouth and triple-blind (operators, patients and evaluator) trial was carried out. Patients (n=42) with at least two non-carious cervical lesions were included. The teeth with NCCL were randomly assigned to two treatment groups: application of 2% CHX (experimental group) or a placebo solution (control group) for 60s after acid etching and before the adhesive application. A trained and calibrated examiner evaluated the restorations at baseline (1 week) and at each recall (6, 12, 24 and 36 months) using the FDI criteria. A total of 225 restorations were evaluated after 36-month follow-up. Data were subjected to survival analysis using the Kaplan-Meier method, and the log-rank test was used to evaluate the existence of differences between the survival curves (α=0.05).
RESULTS: The restorations survival rate after 36 months of follow-up was 76.1%. There was no difference in the retention and failure rates between the experimental and the control group (p=0.968). There was an increased failure trend when restorations were located subgingival compared to those at the gingival level or supragingival.
CONCLUSION: The pre-treatment with 2% chlorhexidine digluconate did not promote further restoration retention of noncarious cervical lesions. CLINICAL SIGNIFICANCE: The cavity pre-treatment with chlorhexidine for inhibition of hybrid layer degradation does not add any beneficial effect to the clinical performance of restorations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesive system; Chlorhexidine; Dental restoration; MMP inhibitor; Noncarious cervical lesions; Randomized controlled trial

Mesh:

Substances:

Year:  2017        PMID: 28237629     DOI: 10.1016/j.jdent.2017.02.014

Source DB:  PubMed          Journal:  J Dent        ISSN: 0300-5712            Impact factor:   4.379


  5 in total

1.  The use of clays for chlorhexidine controlled release as a new perspective for longer durability of dentin adhesion.

Authors:  Lívia Rodrigues de Menezes; Emerson Oliveira da Silva; Lizandra Viana Maurat da Rocha; Isabel Ferreira Barbosa; Marina Rodrigues Tavares
Journal:  J Mater Sci Mater Med       Date:  2019-11-30       Impact factor: 3.896

Review 2.  Bond Strength of Universal Adhesives to Dentin: A Systematic Review and Meta-Analysis.

Authors:  Louis Hardan; Rim Bourgi; Naji Kharouf; Davide Mancino; Maciej Zarow; Natalia Jakubowicz; Youssef Haikel; Carlos Enrique Cuevas-Suárez
Journal:  Polymers (Basel)       Date:  2021-03-07       Impact factor: 4.329

3.  Resin-dentin bond stability of etch-and-rinse adhesive systems with different concentrations of MMP inhibitor GM1489.

Authors:  Maria Elisa da Silva Nunes Gomes Miranda; Eduardo Moreira da Silva; Mariana Flôres de Oliveira; Fabiana Souza Simmer; Glauco Botelho Dos Santos; Cristiane Mariote Amaral
Journal:  J Appl Oral Sci       Date:  2020-04-27       Impact factor: 2.698

Review 4.  Current perspectives on dental adhesion: (1) Dentin adhesion - not there yet.

Authors:  Jorge Perdigão
Journal:  Jpn Dent Sci Rev       Date:  2020-09-23

5.  Influence of different application protocols of universal adhesive system on the clinical behavior of Class I and II restorations of composite resin - a randomized and double-blind controlled clinical trial.

Authors:  Andreia Assis Carvalho; Murillo Martins Leite; Jessica Karla Maia Zago; Carla Aparecida Bernardes Costa Meneses Nunes; Terezinha de Jesus Esteves Barata; Gersinei Carlos de Freitas; Érica Miranda de Torres; Lawrence Gonzaga Lopes
Journal:  BMC Oral Health       Date:  2019-11-21       Impact factor: 2.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.